Antibody formulations
US10010611B2 · kind B2 · utility
3Cited by
52References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 13, 2014 |
| Grant date | Jul 3, 2018 |
| Priority date | — |
| Expiry date | Mar 14, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K16/2887
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides stable aqueous pharmaceutical formulations comprising a therapeutic antibody, trehalose, a buffer, and optional surfactant, and having a pH in the range of about 5.5 to about 7.0. The invention also provides methods for making such formulations and methods of using such formulations.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.